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A new imidazole alkaloid (1) along with two known 
compounds, variabilin (2) and iricinialactam A (3) have been 
isolated from the Arabian marine sponge Ircinia fusca. The 
structure of the new compound was established as 4-((1, 2-
dihydroxy-5-(methyl (1-methyl-1H-imidazol-4-yl) amino) pentan-
3-yl) oxy)-3, 5-dimethoxy-1-methylpyrrolidin-2-one (1) by 1D and 
2D NMR, and high-resolution electrospray ionization mass 
spectrometry (HRESIMS). Compound 1 exhibited selective growth 
inhibitory activity against gram-positive bacteria S. aureus at 100 
µg/mL. 
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alkaloids, Mass spectrometry, NMR, Sponge. 
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Introduction 
Marine sponges are a rich source of metabolites 
reported in marine libraries1-3 among them; sponges of 
the genus Iricina have been proven to be a rich source 
of diverse biologically active secondary metabolites 
with novel chemical structures4-7. Several molecules 
isolated form Iricina species exhibited antineoplastic, 
antifouling, anti-inflammatory, cytotoxicity8-10 and 
antimicrobial properties11.  
 
Materials and Methods 
 
Experimental details 
Optical rotations were determined on a Rudolph 
Research Analytical (AUTOPOL V) polarimeter at a 
wavelength of 589 nm (sodium D line) using a 1.0 dm 
cell with a total volume of 1.0 mL. The UV spectra 
were measured on an Agilent technologies carry 
series UV-VIS spectrophotometer and Infrared 
spectra on Bruker ALPHA. All solvents were of 
analytical grade. Column chromatography was 
performed on Merck silica gel (120-200 mesh) and 
Sephadex LH-20 (Sigma-Aldrich Chemie GmbH). 
Thin layer chromatography was carried out with silica 
gel GF254 plates, Merck, USA. The 1H and 13C, 
DEPT-135, COSY, TOCSY, HSQC, HMBC at 
Bruker 400 MHz (or 100 MHz for 13C). The chemical 
shifts (δ) are reported in ppm and coupling constants 
(J) in Hz. The positive ion HR-ESI-MS spectra were 
recorded on a Mass Q-TOF-LC-MS spectrometer 
(Bruker Daltonics).  
 
Collection of sponge  
The sponge Ircinia fusca (Carter, 1880) was 
collected from Bagwatibandhan (N 18o19.092,’ E 
072o57.343’ West coast of Maharashtra, India in 
February 2016. The sponge was identified by Dr. 
Satish S.Mokashe, Associate Professor, Department 
of Zoology, Dr. Babasaheb Ambedkar Marathwada 
University, India. A voucher specimen (No. 55-25P) 
was deposited in the College of Fisheries, Maharashtra, 
India. 
 
Extraction and isolation 
In the laboratory, the sponge was washed with 
distilled water to remove surface salts, sand, and 
epiphytes. The sponge was dabbed with tissue paper 
to remove excess water, cut into small pieces and 
placed in a lyophilizer to completely dry. The dried 
material was (2 g dried weight) reduced to small 
pieces and extracted with MeOH (0.86 g). Desalting 
of sponge methanolic extract was done with acetone. 
The methanolic extract was concentrated under 
vacuum using a rotary evaporator at 40 oC followed 
by partition between hexane, DCM, water. All the 
partition layers were subjected to preliminary 
bioactivity studies (antibacterial and antifungal) by 
disc diffusion method. 
 
Antimicrobial activity 
The isolated compounds 1-3 were tested against 
antibacterial i.e., Escherichia coli (NCIM 2065), 
Salmonella typhimurium (NCIM 2501), Bacillus 
subtilis (NCIM 2063), Staphylococcus aureus (NCIM 
2079), Mycobacterium smegmatis (NCIM 5138) and 
antifungal strains Aspergillus niger (NCIM 1207), 
Penicillium chrysogenum (NCIM 1315), Alternaria 
————— 
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sp. (NCIM 900), and Fusarium sp. (NCIM 1372). The 
crude extracts were dissolved in DMSO at a 
concentration of 1 mg/mL.  The discs were loaded 
with different concentrations (10- 500 μg/disk) of the 
pure compound, to find out the inhibitory potential. 
The diameters of the inhibition zones generated 
around the discs were measured (Ø in mm). 
Ampicillin was taken as positive control. The tests 
were performed in triplicates. DMSO used to dissolve 
the extracts and the compounds were checked for the 
absence of antimicrobial activity. The diameters of 
the halos of inhibition can be rationalized on a 
qualitative basis as follows: Ø < 7 mm: inactive,  
7 mm ≤ Ø < 8 mm: slightly active, 8 mm ≤ Ø < 9 
mm: significantly active, Ø ≥ 9 mm: very active.  
The compound which showed ≥ 9 mm was selected 
for MIC studies. 
 
Minimum inhibitory concentration (MIC) 
Purified compound was evaluated for MIC values 
against various Gram-positive and Gram-negative 
bacteria test cultures using nutrient broth described by 
Andrews12. 
 
Results and Discussion 
During the course of our search for bioactive 
substances from marine sponges, we collected  
Iricnia fusca from Bagwatibandhan (N 18o 19.092,’ E 
072o57.343’), Arabian Sea, West coast of 
Maharashtra, India. The crude organic methanolic 
extract of the specimen exhibited antimicrobial 
activity in preliminary studies. Chromatographic 
separation of the MeOH extract using C18 semi-
preparative reverse phase HPLC led to the isolation of 
new imidazole derivative (1) as showed in Fig. S1  
and two known compounds variabilin (2) and 
iricinialactam A (3)7 (Fig. 1). Herein, the structure 
elucidation and bioactivity of the new compound  
1 from the I. fusca is described.  
Compound 1 was obtained as a white crystalline 
solid, melting point 110 οC and [α]25D= 13.0 (c 1.0, 
CH3OH). The ESI-MS-QTOF exhibited a pseudo 
molecular ion peak at m/z 425.2155 [M+K] +  
(Fig. S2), corresponding to the molecular formula of 
C17H30N4O6K, indicating four degrees of unsaturation 
and four nitrogen atoms in the molecule. The UV 
absorption at λmax 214 nm indicating the absence of 
chromophore in the compound 1. The IR spectra 
showed bands at 3339, 2946, 2034, 1450, 1120, 1027 
suggested the presence of hydroxyl, lactam, and 
aromatic moieties. Its 1H NMR chemical shifts at δH 
8.85 (s, H-2), δH 7.90 (s, H-5) and 13C NMR signals at 
δC 140.0 (C-2), 131.8 (C), and 128.4 (C-5) were a 
characteristic feature of imidazole ring with C-4 
substitution13. The 1H NMR spectrum of compound 1 
(Fig.S3) showed three singlet's at δH 3.05, 3.91, 4.09 
indicating three N-CH3 groups and one singlet at δH 
3.41 (6H, s) for two methoxy groups and five methine 
signals  at 3.73 (1H, m, H-2'), δH 3.27 (1H, d, J = 10 
Hz, H-3'), 4.67 (1H, d, J = 3.7 Hz. H-3''), 3.60 (1H, d, 
J = 10Hz, H-5''), 3.38 (1H, dd, J = 3.7, 10 Hz, H-4''), 
and three methylene at δH 3.05 (2H, d, J = 10Hz,  
H-4'), 3.60 (2H, d, J = 10Hz, H-1'), 3.53 (2H, m,  
H-5').The 13C, DEPT 135, 13C HSQC  NMR spectrum 
of 1 (Fig. S4, S5, S6)  exhibited total of 17 carbons 
(Table 1) including a carbonyl signal at δC 159.0  
(C-2''), four olefinic methines at δC 140.0 (C-2), 
128.4(C-5), 75.1 (C-5''), 100.8 (C-3''), one quaternary 
carbon δC 131.4(C-4), two methylenes δC 50.4 (C-5'), 
39.8(C-4'), three oxygenated methines at δC 71.8  
 
 
Fig. 1 — Chemical structure of isolated compounds from I. fusca 
Table 1 — NMR data of compounds 1 (400 MHz, CD3OD) 
Position Compound 1 
δH/ppm, multi(J/Hz) δC/ppm 
1 
2 
3 
4 
5 
1' 
2' 
3' 
4' 
5' 
1'' 
2'' 
3'' 
4'' 
5'' 
1' N 
6'N 
1''N 
- 
- 
N 
8.85, s 
N 
- 
7.90, s 
3.60, d, J = 10 Hz 
3.73, m 
3.27, br d, J = 10 Hz 
3.05, d, J =10 Hz 
3.53, m 
N 
- 
4.67, d, J =3.7 Hz 
3.38, brd, J = 10, 3.7 Hz 
3.60, d, J =10 Hz 
4.09,s 
3.91, s 
3.05,s 
3.41, s 
3.41, s 
- 
140.0, CH 
- 
131.4, C 
128.4, CH 
62.7,  CH2 
73.5, CH 
71.8, CH 
39.8,  CH2 
50.4,  CH2 
- 
159.0, CO 
100.8, CH 
73.5, CH 
75.1, CH 
36.6 
36.5 
38.4 
55.5, OCH3 
55.5, OCH3 
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(C-3'), 73.5 (C-2'), 73.5 (C-4''), an oxygenated methylene 
at δC 62.7 (C-1'), two methoxy carbons at δC 55.5, three 
N-methyl carbons at δC 36.5, 36.6, 38.4 respectively.  
The COSY (Fig.S7) correlations between H-4''/H-
3'', H-4''/H-5', as well as the HMBC (Fig.S8) 
correlations from H-3'' to C-2'' revealed the presence 
of pyrrolidin-2-one ring moiety. Further HMBC 
correlations of N-methyl proton δH 3.05  to C-2'', δH 
3.41 (Methoxy) with C-3'', C-5'' asserted the location 
of the methoxy groups at H-3'' and H-5'' positions 
respectively as shown in Fig. 2, which confirmed 3, 5 
dimethoxy -1-methyl pyrrolidin-2-one moiety in 
compound 1. The 1H signals at δH 3.54 and 3.68 and 
correlations of H-5'-H-4'-H-3'-H-2'-H-1' observed in 
the COSY spectrum, in combination with HMBC 
correlations of H-5' to N-methyl carbon δC 36.6 (C-6') 
revealed the presence of amino pentyl moiety in 
compound 1. Furthermore, HMBC correlations of 6'N 
to C-4 and H-3' to C-4'' revealed 3, 5 dimethoxy -1-
methyl pyrrolidin-2-one was linked to 1-methyl-1H-
imidazol-4-yl-amino-pentan-3-yl-oxy through ether 
linkage showed in Fig. 2. Thus, the structure 
compound 1 was established as 4-((1, 2-dihydroxy-5-
(methyl (1-methyl-1H-imidazol-4-yl) amino) pentan-
3-yl) oxy)-3,5-dimethoxy-1-methylpyrrolidin-2-one 
as shown in Fig. 1  
Compound 1 to 3 were evaluated for their antifungal 
activity against A. niger (NCIM 1207), P. chrysogenum 
(NCIM 1315), Alternaria sp (NCIM 900), Fusarium sp 
(NCIM 1372) as well as antibacterial activity against  
E. coli (NCIM 2065), S. typhimurium (NCIM 2501),  
B. subtilis (NCIM 2063) and S. aureus (NCIM 2079) 
was also tested using the disc diffusion assay14. Neither 
antifungal, nor antibacterial activity was recorded for 
the compounds (2 and 3), but compound 1 exhibited 
selective inhibitory growth activity against S. aureus 
when compared with ampicillin disc at 100 µg/mL. 
The MIC of compound 1 was found to be 280 µM. 
This indicates its use as a potential drug against gram-
positive bacteria which causes nosocomial infections in 
hospitals, especially S. aureus. We are pursuing the 
activity of this drug against methicillin-resistant 
Staphylococcus aureus strains. 
Conclusion 
Until now, sponge species like Leucetta15 and 
Leucosolenia16 have been reported as rich sources of 
imidazole alkaloids. This is the first report that the 
sponge Iricinia fusca, taken from the West coast of 
Maharashtra, produces a new imidazole alkaloid as a 
natural product. The isolated compound 1 was similar 
to 2,5-Pyrrolidinedione, 1,1'-(1,4-butanediyl)bis[3-
ethoxy-) with CAS Registry Number 1403656-78-9, 
which was found in SciFinder to be synthesized via a 
chemical reaction. 
In summary, three compounds were isolated from  
I. fusca. Compound 1 has been reported as a  
new alkaloid metabolite isolated from I. fusca and  
the structure was elucidated by NMR and mass 
spectroscopic analysis. The genus Iricina has been 
known to produce diverse metabolites like sesterterpenoids, 
irciniastatins, quinones, ircinialactams, and pyrroles, but 
the current study also showed the presence of new 
imidazole derivative from I.fusca. These reports indicate 
that a large resource of metabolites with biological 
significance may yet be disclosed in I. fusca. 
Compound 1: 1H NMR (400 MHz, MeOD) δ 8.85 (s, 
1H), 7.90 (s, 1H), 4.67 (d, J = 3.7 Hz, 1H), 4.09 (s, 3H), 
3.91 (s, 3H), 3.73 (m,1H), 3.60 (d, J= 10H, 3Hz, 3H), 
3.53 (m, 2H), 3.38 (br d, J= 10, 3.7 Hz, 1H), 3.41 (s, 
6H),  3.27 (d, J = 10 Hz, 1H), 3.05 (d, J = 10.0 Hz, 5H). 
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